FDA Investigator Gabriel R Mclemore
Gabriel R Mclemore has inspections in 1 countries as of 04 Aug 2022. Gabriel R Mclemore has collaborated with a combinined 2932 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
47
Last Inspection Date:
04 Aug 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron P Wozniak,
Abdur Rashid,
Adam J Williams,
Adam R Cooke,
Alphonso A Haupt, III,
Amanda L Evanco,
Amy H Ruble,
Anthony S Puckett,
Arlyss M Jones,
Arthur G Hurst,
Aylyss M Jones,
Babatunde D Babalola,
Barbara M Frazier,
Beth F Fritch,
Betsy C Galliher,
Billy M Battles,
Bonita S Chester,
Brandy D Brown,
Brown,
Burnell M Henry,
Carlos A Ortiz,
Carlos M Gonzalez,
Carol F Robinson,
Carol J Blackwood,
CDR Thomas R Berry, PPh,
Cherrie A Zachary,
Christian D Lynch (CDL),
Christie B Rice,
Christina H Owens,
Christine M O'leary,
Christopher J Adams,
Christopher S Keating,
Claire M Minden,
Claudette D Brooks,
Constance Y Fears,
Contractor Bridgers,
Cordelia J Brammer,
Cynthia Jim, CSO,
D Ross Spears, PhD,
Daphne Santiago, PhD,
David T Glover,
Devaughn Edwards,
Donald C Obenhuber, PhD,
Edward Deberry,
Eileen J Bannerman,
Eric S Weilage,
Erin C Hill,
Ernest H Blackwood,
Fabian Nchaparro Rodriguez,
Ford,
Frank Wackes,
Gabriel M Guevarra,
Gabriel Mclemore,
Geraldine D Sanders,
Gerraldine Sanders,
Gideon N Esuzor,
Gray,
Hai Lien Phung,
Hai Lien T Phung,
Hector A Carrero,
Ibad U Khan,
Igbinoba,
Ivery,
Ivy E Sweeney,
Jacqueline D Mitchell,
Jacqueline Mdiaz Albertini,
Jamirya S Weatherly,
Jaqueline Mitchell,
Jared P Stevens,
Jason F Chancey,
Jason R Nickelsen,
Jawaid Hamid,
Jawid Hamid,
Jeffrey D Sheppard,
Jennifer D Hollstrom,
Joanne T Gabay,
Johnetta F Walters,
Jonathan G Swoboda,
Joseph F Owens,
Karen L Anderson,
Katelynn J Gulya,
Katelynn J Rollins,
Kathleen D Culver,
Keri U Walker,
Kimberly Cdelk Brooks,
King,
Kip J Hanks,
Lareese K Thomas,
Larry K Hampton,
Laura D Cain,
Laura L Staples,
Lawrence Carter, III,
Lawrence Thomas,
Leah Andrews,
Leah M Andrews,
Leroy M Anderson,
Lesley K Satterwhite,
Leslie W Gilbert,
Lorenzo Jones,
LT Daveta L Bailey,
LT Tamara J Henderson,
Luis M Burgos Medero,
Marcia Gelber,
Marie F Morin,
Matthew G Brown,
Melanie M Walker,
Michele L Forster, PhD,
Michelle D Haamid,
Michelle Y Clark Stuart,
Monica Cburgos Garcia,
Myla D Chapman,
Myoshi M Francis,
Nicole A Lloyd,
Omotunde O Osunsanmi,
Paul W Moy,
Penny H Mccarver,
Perry H Gambrell,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
R Edwadebey Deberry,
Rachael L Cook,
Randy L Clarida,
Reba A Gates,
Rebecca Rodriguez,
Rhonda Alexander,
Richard L Garcia,
Robert C Coleman,
Robert D Tollefsen,
Robert L Lewis, Jr,
Robert P Neligan,
Robert W Turner,
Rose M Ashley,
Scott T Ballard,
Seneca D Toms,
Sharna D Pratt,
Shayla G Turnipseed,
Sheri S Oliver,
Shirley S Brown,
Simone M Edmonson,
Sonya M Edmonds,
State Agency,
Steven J Rush,
Steven M Weinman,
Susan O Oladeji,
T Lindaswart Stewart,
Tajah L Blackburn,
Tamara M Casselman,
Tamika D Cathey,
Tammara A Stephens,
Theresa L Stewart,
Thomas R Barry,
Thomas R Withers,
Tomika L Bivens,
Tracy R Ball,
Trang N Cox,
Trang P Nguyen,
Vanessa E Coulter,
Veronica Fuentes, MS,
Vicky C Stoakes,
Viviana Matta,
Walker,
William P Tonkins,
Yiyue Zhang (nmi), PhD,
Young Kim,
Yun Wu, PhD,
Zhong Li, PhD
Gabriel R Mclemore's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| May, 2010 | FDA 483 | P & L Development, LLC - Form 483, 2010-05-13 |
| April, 2011 | EIR | Covidien LP - EIR, 2011-04-21 |
| March, 2010 | FDA 483 | Chiesi USA, Inc. - Form 483, 2010-03-24 |
| August, 2010 | FDA 483 | Liebel-Flarsheim Company LLC - Form 483, 2010-08-20 |
| August, 2009 | FDA 483 | River's Edge Pharmaceuticals, LLC - Form 483, 2009-08-12 |
| August, 2009 | FDA 483 Response | River's Edge Pharmaceuticals, LLC - Form 483R, 2010-01-20 |
| January, 2010 | FDA 483 | Dixon Investments Inc - Form 483, 2010-01-25 |
| April, 2009 | EIR | Hospira, Inc. - EIR, 2009-04-29 |
| August, 2011 | EIR | Pfizer Inc - EIR, 2011-08-25 |
| April, 2009 | FDA 483 | STAT RX USA LLC - Form 483, 2009-04-29 |
| August, 2009 | FDA 483 | Baxter Healthcare Corporation - Form 483, 2009-08-19 |
| October, 2010 | FDA 483 | ISE Newberry Inc. - Form 483, 2010-10-15 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more